Q2 2024 EPS Estimates for TG Therapeutics, Inc. Increased by Analyst (NASDAQ:TGTX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics, Inc. Forecasted to Post FY2025 Earnings of $0.11 Per Share (NASDAQ:TGTX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […]
HC Wainwright Raises TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Get Free Report) had its price target boosted by research analysts at HC Wainwright from $45.00 to $49.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 202.66% from the company’s […]
TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02), Briefing.com reports. The company had revenue of $63.47 million during the quarter, compared to analyst estimates of $54.60 million. TG Therapeutics had a net […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 13,983 call options on the stock. This is an increase of approximately 88% compared to the average volume of 7,433 call options. Insider Activity In related news, Director Laurence N. Charney sold 22,000 […]
Avaii Wealth Management LLC cut its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 13.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,283 shares of the biopharmaceutical company’s stock after selling 4,739 shares during the […]
Avaii Wealth Management LLC lowered its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 13.9% in the fourth quarter, Holdings Channel reports. The firm owned 29,283 shares of the biopharmaceutical company’s stock after selling 4,739 shares during the quarter. Avaii Wealth Management LLC’s holdings in TG Therapeutics were worth $500,000 as of its […]
HC Wainwright reiterated their buy rating on shares of TG Therapeutics (NASDAQ:TGTX – Free Report) in a research note published on Thursday, Benzinga reports. HC Wainwright currently has a $45.00 price target on the biopharmaceutical company’s stock. TGTX has been the subject of a number of other reports. The Goldman Sachs Group boosted their price […]